Aino Health AB (publ) (AINO.ST)
SEK 0.14
(0.0%)
SEK 0.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.66 Million SEK | 30.62% |
| 2022 | -15.36 Million SEK | 6.99% |
| 2021 | -16.52 Million SEK | -29.37% |
| 2020 | -12.77 Million SEK | 16.4% |
| 2019 | -15.27 Million SEK | 30.58% |
| 2018 | -22 Million SEK | 30.78% |
| 2017 | -31.79 Million SEK | -430.63% |
| 2016 | -5.99 Million SEK | -509.5% |
| 2015 | 1.46 Million SEK | 260.24% |
| 2014 | -913 Thousand SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.94 Million SEK | 23.58% |
| 2024 Q2 | -2.01 Million SEK | 31.46% |
| 2023 Q4 | -3.85 Million SEK | -216.95% |
| 2023 FY | -10.66 Million SEK | 30.62% |
| 2023 Q1 | -3.04 Million SEK | 37.32% |
| 2023 Q2 | -2.8 Million SEK | 7.82% |
| 2023 Q3 | -1.21 Million SEK | 56.72% |
| 2022 Q4 | -4.85 Million SEK | -49.62% |
| 2022 FY | -15.36 Million SEK | 6.99% |
| 2022 Q2 | -3.75 Million SEK | 3.77% |
| 2022 Q1 | -3.9 Million SEK | -1.25% |
| 2022 Q3 | -3.24 Million SEK | 13.48% |
| 2021 Q3 | -4.78 Million SEK | -58.9% |
| 2021 FY | -16.52 Million SEK | -29.37% |
| 2021 Q1 | -3.57 Million SEK | -34.82% |
| 2021 Q2 | -3.01 Million SEK | 15.63% |
| 2021 Q4 | -3.85 Million SEK | 19.52% |
| 2020 Q4 | -2.64 Million SEK | -11.12% |
| 2020 FY | -12.77 Million SEK | 16.4% |
| 2020 Q3 | -2.38 Million SEK | 47.8% |
| 2020 Q1 | -3.56 Million SEK | 10.82% |
| 2020 Q2 | -4.56 Million SEK | -27.91% |
| 2019 FY | -15.27 Million SEK | 30.58% |
| 2019 Q4 | -4 Million SEK | -27.98% |
| 2019 Q3 | -3.12 Million SEK | 35.92% |
| 2019 Q2 | -4.88 Million SEK | -49.37% |
| 2019 Q1 | -3.26 Million SEK | 5.06% |
| 2018 FY | -22 Million SEK | 30.78% |
| 2018 Q1 | -7.27 Million SEK | 15.98% |
| 2018 Q2 | -5.82 Million SEK | 19.99% |
| 2018 Q3 | -5.46 Million SEK | 6.22% |
| 2018 Q4 | -3.44 Million SEK | 37.0% |
| 2017 Q2 | -8.55 Million SEK | -57.74% |
| 2017 Q3 | -9.18 Million SEK | -7.43% |
| 2017 Q4 | -8.66 Million SEK | 5.69% |
| 2017 FY | -31.79 Million SEK | -430.63% |
| 2017 Q1 | -5.42 Million SEK | -50.79% |
| 2016 Q4 | -3.59 Million SEK | 0.0% |
| 2016 FY | -5.99 Million SEK | -509.5% |
| 2015 FY | 1.46 Million SEK | 260.24% |
| 2014 FY | -913 Thousand SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bonzun AB (publ) | 13.88 Million SEK | 176.784% |
| Kontigo Care AB (publ) | 212 Thousand SEK | 5128.774% |
| Medhelp Care Aktiebolag (publ) | -11.01 Million SEK | 3.17% |
| RaySearch Laboratories AB (publ) | 81.57 Million SEK | 113.069% |
| Surgical Science Sweden AB (publ) | 233.97 Million SEK | 104.557% |